Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF).
about
Assessing bleeding risk in patients taking anticoagulantsAntithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesWarfarin with fluoroquinolones, sulfonamides, or azole antifungals: interactions and the risk of hospitalization for gastrointestinal bleedingEmerging Tools for Stroke Prevention in Atrial FibrillationManaging atrial fibrillation in the very elderly patient: challenges and solutionsAnticoagulant Treatment of Deep Vein Thrombosis and Pulmonary Embolism: The Present State of the ArtAtrial fibrillation in patients with diabetes: molecular mechanisms and therapeutic perspectivesThe HAS-BLED Score for Predicting Major Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: A Systematic Review and Meta-analysisAssessing the risk of recurrent venous thromboembolism--a practical approachVenous thromboembolism: Predicting recurrence and the need for extended anticoagulationPhenotyping bleedingDeveloping an Atrial Fibrillation Guideline Support Tool (AFGuST) for shared decision making.2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.Re-initiation of dabigatran and direct factor Xa antagonists after a major bleedAnemia: An Independent Predictor Of Adverse Outcomes In Older Patients With Atrial FibrillationUntreated atrial fibrillation in the United Kingdom: Understanding the barriers and treatment optionsOptimising stroke prevention in non-valvular atrial fibrillationAnticoagulation in atrial fibrillationStroke Prevention in Atrial Fibrillation: Focus on Latin AmericaMajor Bleeding in Patients with Non-Valvular Atrial Fibrillation: Impact of Time in Therapeutic Range on Contemporary Bleeding Risk ScoresAtrial fibrillation in women: treatmentA generalised model for individualising a treatment recommendation based on group-level evidence from randomised clinical trials2014 AATS guidelines for the prevention and management of perioperative atrial fibrillation and flutter for thoracic surgical procedures.MRI screening for chronic anticoagulation in atrial fibrillationPolypharmacy is associated with an increased risk of bleeding in elderly patients with venous thromboembolismThe challenge of bleeding in antiphospholipid antibody-positive patients.Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.Personalized prophylactic anticoagulation decision analysis in patients with membranous nephropathy.Erratum: utilization of anticoagulation therapy in medicare patients with nonvalvular atrial fibrillationIndividualized medical decision making: necessary, achievable, but not yet attainable.Bleeding complications associated with warfarin treatment in ischemic stroke patients with atrial fibrillation: a population-based cohort study.Risk score to predict serious bleeding in stable outpatients with or at risk of atherothrombosis.Risk scores and geriatric profile: can they really help us in anticoagulation decision making among older patients suffering from atrial fibrillation?The economic burden of ischemic stroke and major hemorrhage in medicare beneficiaries with nonvalvular atrial fibrillation: a retrospective claims analysis.Anticoagulation in Patients Aged ≥75 years with Atrial Fibrillation: Role of Novel Oral Anticoagulants.A review of the safety of anticoagulants in older people using the medicines management pathway: weighing the benefits against the risksSafe use of antithrombotics for stroke prevention in atrial fibrillation: consideration of risk assessment tools to support decision-makingPredicting risk of upper gastrointestinal bleed and intracranial bleed with anticoagulants: cohort study to derive and validate the QBleed scores.Implementing genotype-guided antithrombotic therapy.Development of a tool to improve the quality of decision making in atrial fibrillation.
P2860
Q24619070-C29E67C0-E67B-498B-B1F9-6F376F92FCA4Q24633053-693F9932-4F7E-4303-989A-4AE20C868B68Q24647605-69BC0EA2-1672-4915-96EF-EA07CE6A7820Q26765023-F7FB958E-DC00-4238-97FD-B06685E60300Q26775877-B26290E2-9C2B-488F-AFDF-0A14A7769EF9Q26776112-24CAE4F0-38CE-4DED-8E3C-88236D49133EQ26778659-8951CD7B-D4F6-4C24-8729-354C142B6E0EQ26784497-73B0FCF2-077A-4FDA-B3B4-10C3EA54BF0AQ26796430-8BE591F5-DC27-4256-850F-340F87D96957Q26825608-A28FFCA4-9886-42A8-87AD-300989485F25Q26830732-2DAFAFF2-A484-4E35-8F01-6DA660F0282AQ27321275-7AC04AA7-0C8C-45CE-8D67-98E8E732CBA0Q27341873-1E8236BA-90F5-41F2-A1D7-8257B2CDE2B4Q28067358-F437D34E-E726-44C4-A5CC-54D44DAEDD15Q28073527-8824D723-3D90-4CA7-95BF-DDF801618B5DQ28081837-45260A44-EB9E-4114-939B-623E13A4CE4BQ28200609-750618DC-1078-4590-9E2E-84D6CB01C812Q28315636-10A30D53-1A1F-4BA4-8082-812566F76E43Q28359631-456D8499-9109-4F42-B3E7-446E5520DA08Q29544821-A6272DD6-091B-450D-B669-DD89F7C9210EQ30241862-61A951EF-0E1A-445A-88CF-46EE84FEB2D4Q30543580-D63C9A9E-BC13-40CC-B010-F4C9FA8CBDA7Q30653045-99C00C9B-87C3-4873-8288-BD4CBE589830Q30673203-3152B49B-7F18-44D9-B0CD-242A888325CFQ33417203-A6546836-5C07-4632-BFC8-F8012B5E7448Q33419972-9D261DCA-DC7B-4654-A88F-2F438A02696BQ33572430-0BD67F5A-4796-4F00-A197-ED049FFAA657Q33692552-ED0724BD-C021-490F-96FF-6A40383C4079Q33714864-8864385E-C9B2-45AA-8294-0BB3BEC31832Q33752536-EB5126B0-DF2A-4C85-AF65-D04A9152B5F8Q33841770-6694BCF7-DC23-46C9-BC9A-2FC59F696F8BQ33849056-C223EDE6-93A3-4590-9301-ACB7F39A439DQ33927278-8E6B28B1-781B-434F-9003-161A5E5B7E98Q33928951-223DC4D1-415A-44CC-82C3-19AC8E512584Q33936087-97A8FF38-ACEC-4B16-842B-FB545A9B0ADFQ33949244-C9EDEBDF-C2C2-4DCA-905F-04E19B4C06DFQ33949571-915687B1-EA0B-4C2A-B4AF-C6E2E8B11334Q33960850-1812ABA9-AEE3-40F7-84D6-EB68CA80B53DQ33990428-30C1BFAF-0A87-4807-94A1-980328465A45Q34041787-2615E992-FDB5-4C93-9C3F-7D491EF76E91
P2860
Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF).
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Clinical classification scheme ...... of Atrial Fibrillation (NRAF).
@en
Clinical classification scheme ...... egistry of Atrial Fibrillation
@nl
type
label
Clinical classification scheme ...... of Atrial Fibrillation (NRAF).
@en
Clinical classification scheme ...... egistry of Atrial Fibrillation
@nl
prefLabel
Clinical classification scheme ...... of Atrial Fibrillation (NRAF).
@en
Clinical classification scheme ...... egistry of Atrial Fibrillation
@nl
P2093
P50
P1476
Clinical classification scheme ...... of Atrial Fibrillation (NRAF).
@en
P2093
Brian F Gage
Michael W Rich
Robert Culverhouse
P304
P356
10.1016/J.AHJ.2005.04.017
P407
P577
2006-03-01T00:00:00Z